TEOSYAL® PURESENSE ULTIMATE (2x1ml)

Product Overview: TEOSYAL® PURESENSE ULTIMATE (2x1ml)

TEOSYAL® PURESENSE ULTIMATE (2x1ml) is a sterile, non-pyrogenic, transparent, highly cross-linked hyaluronic acid (HA) gel of non-animal origin, formulated with 0.3% lidocaine hydrochloride for improved patient comfort. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this high-viscosity product is engineered for substantial volume creation and facial sculpting. Presented in a package containing two 1ml syringes, this format offers flexibility for precise treatments, bilateral applications, or staged procedures requiring deep injection into the subdermal or pre-periosteal layers.

This product is indicated for restoring significant volume loss and remodeling facial contours, particularly in areas such as the cheeks, chin, jawline, and temples.

Note: TEOSYAL® PURESENSE ULTIMATE (2x1ml) is intended for use only by licensed medical professionals possessing thorough knowledge of facial anatomy and expertise in deep-plane injection techniques for volumizing fillers.

Mechanism of Action and Properties

TEOSYAL® PURESENSE ULTIMATE delivers significant volumizing effects due to its high HA concentration and degree of cross-linking. Its dense, cohesive gel structure provides robust tissue support and lift when injected deeply. The formulation prioritizes projection and stability for effective facial sculpting. The integrated 0.3% lidocaine hydrochloride provides local anesthesia, enhancing patient comfort during treatment. The hyaluronic acid component also aids tissue hydration.

The extensive cross-linking contributes to the product’s longevity, with clinical effects potentially lasting up to 18 months, although individual results vary. The 2x1ml format allows practitioners versatility in addressing patient needs, whether for balanced bilateral augmentation or tailored volume placement.

Indications and Usage

TEOSYAL® PURESENSE ULTIMATE (2x1ml) is indicated for addressing significant volume loss and enhancing facial architecture, including:

• Malar (cheekbone) augmentation
• Zygomatic arch definition
• Chin projection and reshaping
• Jawline contouring and definition
• Correction of severe facial lipoatrophy
• Temple volumization

Administration involves deep injection techniques (subdermal or supra-periosteal) by qualified practitioners using appropriate needles or cannulas and adhering to strict aseptic procedures. The 2x1ml presentation is suitable for various volumizing strategies.

Expected Outcomes

Professional application aims to achieve:

• Significant augmentation of facial volume in targeted areas
• Enhanced facial projection and definition (e.g., cheeks, chin)
• Improved overall facial contours and structure
• Correction of deep volume deficits and concavities
• Long-lasting results for facial remodeling
• Improved patient comfort due to lidocaine inclusion

Potential Adverse Events

Given the deep injection placement and potential volumes used, practitioners must carefully discuss potential side effects. Possible adverse events include:

• Common Reactions (Typically Transient): Post-injection swelling, bruising, erythema (redness), pain, tenderness, palpable firmness or lumpiness at the injection site. These usually resolve within one to two weeks.
• Less Common/Rare but Serious Reactions: Prolonged swelling or firmness, significant hematoma, infection, inflammation, hypersensitivity/allergic reaction (to HA or lidocaine), nodule or granuloma formation (potentially delayed onset), skin discoloration, abscess formation, contour irregularities, vascular complications (compression or intravascular injection, rare but serious, requiring immediate intervention), nerve impingement/effects (rare), tissue necrosis (rare).

A thorough understanding of deep facial anatomy, safe injection planes, and management of potential complications is essential. Patients must report any severe, persistent, or concerning reactions promptly.

Storage Conditions

Store between 2°C and 25°C. Avoid freezing and direct sunlight exposure. Ensure packaging integrity before use.

Disclaimer: This summary is for informational purposes only. Healthcare professionals must consult the full instructions provided with TEOSYAL® PURESENSE ULTIMATE (2x1ml) before administration for complete details on product characteristics, indications, contraindications, warnings, precautions, injection procedures, and potential adverse events.